Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05956158 · ClinicalTrials.gov registry record · NA

RISE: A Remote Study of Insomnia Treatment in Crohn's Disease

A NA study of Insomnia and Crohn Disease, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT05956158 is a NA study of Insomnia and Crohn Disease that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 83 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05956158, a NA study of Insomnia and Crohn Disease, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Treatment
  • BEHAVIORAL Sleep Education Treatment

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2023-11-28
Est. Completion 2026-11-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT05956158

The ClinicalTrials.gov registry entry for NCT05956158 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (51% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Treatment is the first listed.

NCT05956158 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05956158 about?

NCT05956158 is a clinical study titled "RISE: A Remote Study of Insomnia Treatment in Crohn's Disease". The purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.

What is the current status of trial NCT05956158?

This trial is currently recruiting. It is a NA study. The enrollment target is 83 participants. The study started on 2023-11-28. Estimated completion is 2026-11-30.

What conditions does trial NCT05956158 study?

This clinical trial studies the following conditions: Insomnia, Crohn Disease.

What interventions are being tested in trial NCT05956158?

The interventions under investigation include: Behavioral Treatment (BEHAVIORAL), Sleep Education Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05956158?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05956158 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.